85 - Improved Survival with Dual Immunomodulator Treatment of ARDS by blocking C5a and IL-6 Activity: Subanalysis from the PANAMO Study in Critically Ill COVID-19 Patients

Thursday, October 17, 2024

11:15 AM – 11:30 AM US PT

Location: 404 AB

Presenting Author(s)

Roy F. Chemaly, MD/MPH (he/him/his)

Gerald P Bodey, Sr Distinguished Professor of Infectious Diseases
University of Texas MD Anderson Cancer Center
Houston, TX, United States

Slides

Co-Author(s)

AV

Alexander Vlaar, MD, PhD

Amsterdam UMC
Amsterdam, Noord-Holland, Netherlands
EL

Endry H.T. Lim, MD, PhD

Amsterdam UMC
Amsterdam, Noord-Holland, Netherlands
Bruce P. Burnett, PhD (he/him/his)

VP, Head of Medical Affairs
InflaRx GmbH, InflaRx Pharmaceuticals, Inc.
Fuquay Varina, NC, United States
CC

Camilla Chong, MD

Chief Medical Officer
InflaRx GmbH
London, England, United Kingdom
sR

simon Rückinger, PhD

Metranomia Clinical Research GmbH
Munich, Bayern, Germany
RZ

Robert Zerbib, MSc

InflaRx GmbH
Jena, Thuringen, Germany
RP

Raymond M. Panas, PhD

Senior Medical Science Liaison
InflaRx Pharmaceuticals, Inc.
Pittsburgh, Pennsylvania, United States
RG

Renfeng Guo, MD

InflaRx GmbH
Jena, Schleswig-Holstein, Germany
NR

Niels Riedemann, MD, PhD

InflaRx GmbH
Jena, Thuringen, Germany
Dv

Diederik van de Beek, MD, PhD

Amsterdam UMC
Amsterdam, Noord-Holland, Netherlands

Disclosure(s):

Roy F. Chemaly, MD/MPH: AiCuris: Advisor/Consultant, Grant/Research Support; Ansun Pharmaceuticals: Advisor/Consultant, Grant/Research Support; Astellas: Advisor/Consultant; Eurofins-Viracor: Grant/Research Support; InflaRX: Advisor/Consultant; Janssen: Advisor/Consultant; Karius: Advisor/Consultant, Grant/Research Support; Merck/MSD: Advisor/Consultant, Grant/Research Support; Moderna: Advisor/Consultant; Oxford Immunotec: Advisor/Consultant, Grant/Research Support; Roche/Genentech: Advisor/Consultant, Grant/Research Support; Shinogi: Advisor/Consultant; Takeda: Advisor/Consultant, Grant/Research Support; Tether: Advisor/Consultant

Alexander Vlaar, MD, PhD: InflaRx GmbH: Advisor/Consultant

Endry H.T. Lim, MD, PhD: No financial relationships to disclose

Bruce P. Burnett, PhD: InflaRx Pharmaceuticals, InflaRx GmbH: Employee

Camilla Chong, MD: InflaRx GmbH: Employee

simon Rückinger, PhD: InflaRx GmbH: Advisor/Consultant

Robert Zerbib, MSc: InflaRx GmbH: Advisor/Consultant

Raymond M. Panas, PhD: InflaRx Pharmaceuticals, InflaRx GmbH: Employee

Renfeng Guo, MD: InflaRx GmbH: Board Member, Chief Scientific Officer, Ownership Interest, Stocks/Bonds (Public Company)

Niels Riedemann, MD, PhD: InflaRx GmbH: Board Member, Chief Executive Officer, Ownership Interest, Stocks/Bonds (Public Company)

Diederik van de Beek, MD, PhD: InflaRx GmbH: Advisor/Consultant